Why the study?
Mitral annular calcification is observed in 18% of patients undergoing mitral surgery and poses unique technical challenges with high operative mortality and major complications.
Mitral annular calcification poses significant surgical challenges with high complication rates, prompting the emergence of TMVR as a therapeutic alternative.
No takes yet. Share an insight, caveat, or question.
High surgical risks in MAC warrant exploring TMVR; leaves open need for prospective trials before practice change.
Ureña et al. (2022) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: